Vetoquinol S A
Vetoquinol S A (Vetoquinol) is a publicly traded company primarily engaged in the animal healthcare. The company is mainly involved in the nursing of animals and improving their well-being. Its activities include research and development, manufacturing, marketing and sale of veterinary medicines and nutraceuticals. Vetoquinol offers a range of products including anti-infectives, anti-inflammatories, and also for cardiovascular diseases such as heart failure. It targets species including dogs, cats, cattle and pigs. The company markets it products with the brand names aurizon, clavaseptin, ipakitine, marbocyl, propalin, prilium, reprocine, tolfine, tolfedine , and zentonil. Vetoquinol sells its products in Europe, North America, Africa, the Middle East, and the Pacific Asia through a distribution network as well as sales and marketing teams. The company is headquartered at Lure, France.
Company Index Score
| Current Index Score | Historical Index Score |
![]() |
|
| |
Latest tweets
More from New Statesman
- Online writers:
- Steven Baxter
- Rowenna Davis
- David Allen Green
- Mehdi Hasan
- Nelson Jones
- Gavin Kelly
- Helen Lewis
- Laurie Penny
- The V Spot
- Alex Hern
- Martha Gill
- Alan White
- Samira Shackle
- Alex Andreou
- Nicky Woolf in America
- Bim Adewunmi
- Glosswitch
- Kate Mossman on pop
- Ryan Gilbey on Film
- Martin Robbins
- Rafael Behr
- Eleanor Margolis
- Tools and services:
- Polls
- Predictions
- Archive
- Magazine
- PDF edition
- RSS feeds
- Advertising
- Subscribe
- Special supplements
- Stockists

